Cardiology

Understanding Lipoprotein(a)- Novel Therapeutics to Reduce Lp(a) Levels and Improve Cardiovascular Outcomes
http://academiccme.com/wp-content/uploads/2018/10/iStock-1035980904-1-wpcf_80x80.jpg
This CME/CNE program will highlight content presented at the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany…
Post Conference Review and Analysis
Identifying Financial and/or Treatment Access Barriers: Patient Perspectives
http://academiccme.com/wp-content/uploads/2018/08/Underberg-Module-4-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. James A. Underberg, along with Dr Christopher P. Cannon, course chair, will identify barriers to caring for dyslipidemia patients…
Webcast
Clinical Trial Analysis of PCSK9 Inhibitors: The Impact of Real-World Cardiovascular Outcomes
http://academiccme.com/wp-content/uploads/2018/08/Blaha-Module-3-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Michael J. Blaha, along with Dr Christopher P. Cannon, course chair, will explore the role of PCSK9 inhibitors in the treatment of dyslipidemia patients and the impact of real-world cardiovascular outcomes…
Webcast
The Role of PCSK9 Inhibitors in Reducing CV Risk: Patient Selection Criteria and Treatment Initiation Tactics
http://academiccme.com/wp-content/uploads/2018/08/Giugliano-Module-2-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Robert P. Giugliano, along with Dr Christopher P. Cannon, course chair, will examine the role of PCSK9 inhibitors in reducing CV risk…
Webcast
Further Insights in Lowering LDL Cholesterol: Managing Atherosclerotic Disease in High-Risk Patients
http://academiccme.com/wp-content/uploads/2018/08/Bonaca-Module-1-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Marc P. Bonaca, along with Dr Christopher P. Cannon, course chair, will discuss options for lowering LDL cholesterol in dyslipidemia patients…
Webcast